遺伝子パネルの世界市場レポート 2025

遺伝子パネルの市場規模は今後数年で急成長が見込まれます。2029年には年間平均成長率（CAGR）15.3％で43億7,000万米ドルに成長します。予測期間における成長の原動力は、慢性疾患やがんの罹患率の上昇、遺伝子検査に対する意識の高まり、政府の取り組みやヘルスケア支出の増加であると予想されます。主な動向としては、遺伝子パネル技術の進歩、戦略的提携、個別化治療アプローチの拡大、人工知能の統合、高度バイオインフォマティクスツールの利用などが挙げられます。

がんの有病率の上昇が遺伝子パネル市場の成長を促進すると予想されます。がんは、制御不能な異常細胞の増殖と拡散を特徴とする疾患群であり、周囲の組織や臓器に侵入して損傷を与える可能性があります。人口の高齢化、ライフスタイルの変化、環境暴露、検出・診断技術の進歩などの要因が、がん患者数の増加に寄与しています。遺伝子パネルは、特定の遺伝子の変異や変化を特定する包括的な遺伝子検査を可能にし、個別化治療戦略を促進し、患者の転帰を改善することで、がん診断において重要な役割を果たしています。例えば、2024年2月、スイスに本部を置く政府間機関である世界保健機関（WHO）は、2022年には970万人ががんで死亡し、2,000万人が新たにがんに罹患したと推定されると報告しました。肺がんが最も多く、新規症例の12.4％を占め、世界で250万人が診断されました。このようながん罹患率の増加が、遺伝子パネル検査の需要を引き続き牽引しています。

遺伝子パネル市場の主要企業は、がん診断および個別化治療アプローチの精度、効率、網羅性を高めるために、先進的なオンコロジーパネルの開発に注力しています。オンコロジーパネルは、がんに関連する複数の遺伝子を解析し、遺伝子変異や変化を特定して診断、予後、治療計画を支援する専門的な遺伝子パネルです。例えば、米国のバイオテクノロジー企業であるVizgen Inc.は、2023年5月にMERFISH PanCancer Pathways Panelを発表し、空間ゲノミクスを研究する科学者にカスタマイズ可能なオプションを提供しました。これらのあらかじめデザインされたパネルは、がん研究を含む様々な研究アプリケーションに最適化されており、信頼性と再現性の高い結果を得るためのエラーロバスト性が強化されています。空間情報を遺伝子発現データと統合することで、このパネルは腫瘍の微小環境や細胞間相互作用に関する深い洞察を提供し、標的を絞ったがん研究や治療開発を促進します。この技術革新は空間生物学における重要なブレークスルーであり、研究者は複雑な生物学的システムをこれまでにない詳細さで解析することができます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界遺伝子パネルPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の遺伝子パネル市場：成長率分析
• 世界の遺伝子パネル市場の実績：規模と成長, 2019-2024
• 世界の遺伝子パネル市場の予測：規模と成長, 2024-2029, 2034F
• 世界遺伝子パネル総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の遺伝子パネル市場製品とサービス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 検査キット
• テストサービス
• 世界の遺伝子パネル市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アンプリコンベース
• ハイブリッド化ベース
• その他のテクノロジー
• 世界の遺伝子パネル市場：設計別、実績と予測, 2019-2024, 2024-2029F, 2034F
• あらかじめデザインされた遺伝子パネル
• カスタマイズされた遺伝子パネル
• 世界の遺伝子パネル市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• がんリスク評価
• 先天性疾患の診断
• 薬理遺伝学
• その他の用途
• 世界の遺伝子パネル市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 調査機関
• 病院
• 診断センター
• 製薬会社
• その他のエンドユーザー
• 世界の遺伝子パネル市場検査キットの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• あらかじめ設計された遺伝子パネル
• カスタマイズされた遺伝子パネル
• 世界の遺伝子パネル市場、テストサービスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• がんリスク評価パネル
• 薬理遺伝子検査パネル
• 神経疾患パネル
• 心血管疾患パネル
• 希少疾患パネル

第7章 地域別・国別分析

• 世界の遺伝子パネル市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の遺伝子パネル市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 遺伝子パネル市場：競合情勢
• 遺伝子パネル市場：企業プロファイル
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Quest Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Intermountain Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Agilent Technologies Inc.
• Illumina Inc.
• Qiagen Inc.
• OPKO Health Inc.
• Myriad Genetics Inc.
• Guardant Health Inc.
• Invitae Corp.
• Integrated DNA Technologies Inc.
• Bio-Rad Laboratories Inc.
• Novogene Corporation
• Fulgent Genetics Inc.
• MedGenome Inc.
• OriGene Technologies Inc.
• Centogene AG
• Blueprint Genetics Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 遺伝子パネル市場2029：新たな機会を提供する国
• 遺伝子パネル市場2029：新たな機会を提供するセグメント
• 遺伝子パネル市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Gene panels are a set of specific genes selected for testing in a single assay to analyze genetic variations associated with particular diseases or conditions. They are utilized for diagnosing genetic disorders, detecting inherited diseases, and enabling personalized treatment plans by examining multiple genes simultaneously, particularly in cancer, rare diseases, and other genetic conditions.

The primary gene panel products and services include test kits and testing services. Test kits are pre-packaged tools containing all necessary reagents and instructions for genetic analysis. These panels employ various technologies, such as amplicon-based and hybridization-based methods, and can be either predesigned or customized. They are applied in cancer risk assessment, congenital disease diagnosis, pharmacogenetics, and other areas, serving end users such as research institutes, hospitals, diagnostic centers, pharmaceutical companies, and others.

The gene panel market research report is one of a series of new reports from The Business Research Company that provides gene panel market statistics, including gene panel industry global market size, regional shares, competitors with a gene panel market share, detailed gene panel market segments, market trends and opportunities, and any further data you may need to thrive in the gene panel industry. This gene panel market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gene panel market size has grown rapidly in recent years. It will grow from $2.14 billion in 2024 to $2.48 billion in 2025 at a compound annual growth rate (CAGR) of 15.5%. The growth in the historic period was driven by the rising prevalence of hereditary disorders, the growing need for genetic screening, increasing research and development activities, the higher incidence of congenital diseases, and the expanding demand for advanced treatment options.

The gene panel market size is expected to see rapid growth in the next few years. It will grow to $4.37 billion in 2029 at a compound annual growth rate (CAGR) of 15.3%. The growth in the forecast period is expected to be driven by the rising incidence of chronic diseases and cancer, growing awareness of genetic testing, and increasing government initiatives and healthcare spending. Key trends include advancements in gene panel technology, strategic collaborations, the expansion of personalized treatment approaches, the integration of artificial intelligence, and the use of advanced bioinformatics tools.

The rising prevalence of cancer is expected to drive the growth of the gene panel market. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells, which can invade and damage surrounding tissues and organs. Factors such as aging populations, lifestyle changes, environmental exposures, and advancements in detection and diagnostic technologies are contributing to the increasing number of cancer cases. Gene panels play a crucial role in cancer diagnosis by enabling comprehensive genetic testing to identify mutations and alterations in specific genes, facilitating personalized treatment strategies and improving patient outcomes. For example, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, reported that an estimated 9.7 million people died from cancer in 2022, with 20 million new cases recorded. Lung cancer was the most prevalent, accounting for 12.4% of all new cases, with 2.5 million diagnoses worldwide. This increasing cancer burden continues to drive demand for gene panel testing.

Leading companies in the gene panel market are focusing on developing advanced oncology panels to enhance the accuracy, efficiency, and comprehensiveness of cancer diagnostics and personalized treatment approaches. Oncology panels are specialized gene panels that analyze multiple genes associated with cancer, identifying genetic mutations and alterations to aid in diagnosis, prognosis, and treatment planning. For instance, in May 2023, Vizgen Inc., a US-based biotechnology company, introduced the MERFISH PanCancer Pathways Panel, providing a customizable option for scientists exploring spatial genomics. These predesigned panels are optimized for various research applications, including cancer studies, and offer enhanced error robustness for reliable and reproducible results. By integrating spatial information with gene expression data, the panels provide deeper insights into tumor microenvironments and cellular interactions, advancing targeted cancer research and therapeutic development. This innovation marks a significant breakthrough in spatial biology, allowing researchers to analyze complex biological systems with unprecedented detail.

In May 2022, Sema4, a US-based health intelligence company, acquired GeneDx in a $322 million transaction. This acquisition bolsters Sema4's position as a leading provider of genomic testing in the U.S., enhancing its health information database to improve patient care and therapeutic development. GeneDx, also based in the U.S., specializes in comprehensive diagnostic services for rare genetic disorders, inherited diseases, and cancers, further strengthening Sema4's capabilities in precision medicine.

Major players in the gene panel market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Intermountain Healthcare, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Qiagen Inc., OPKO Health Inc., Myriad Genetics Inc., Guardant Health Inc., Invitae Corp., Integrated DNA Technologies Inc., Bio-Rad Laboratories Inc., Novogene Corporation, Fulgent Genetics Inc., MedGenome Inc., OriGene Technologies Inc., Centogene AG, Blueprint Genetics Inc., BIONEER Corporation, BGI Group Ltd., Vizgen Inc., Primbio Research Institute LLC.

North America was the largest region in the gene panel market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gene panel report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the gene panel market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gene panel market consists of revenues earned by entities by providing services such as custom panel design, next-generation sequencing, bioinformatics analysis, clinical interpretation, and pharmacogenomics services. The market value includes the value of related goods sold by the service provider or included within the service offering. The gene panel market also includes sales of metabolic disorder panels, reproductive health panels, carrier screening panels, and neurological disorder panels. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gene Panel Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gene panel market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gene panel ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gene panel market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product And Services: Test Kits; Testing Services
• 2) By Technology: Amplicon-Based; Hybridization-Based; Other Technologies
• 3) By Design: Predesigned Gene Panel; Customized Gene Panel
• 4) By Application: Cancer Risk Assessment; Diagnosis Of Congenital Diseases; Pharmacogenetics; Other Applications
• 5) By End-User: Research Institutes; Hospital; Diagnosis Centers; Pharmaceutical Companies; Other End-Users
• Subsegments:
• 1) By Test Kits: Predesigned Gene Panels; Customized Gene Panels
• 2) By Testing Services: Cancer Risk Assessment Panels; Pharmacogenetic Testing Panels; Neurological Disorder Panels; Cardiovascular Disease Panels; Rare Disease Panels
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Quest Diagnostics Inc.; Intermountain Healthcare; Eurofins Scientific SE
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gene Panel Market Characteristics

3. Gene Panel Market Trends And Strategies

4. Gene Panel Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Gene Panel Growth Analysis And Strategic Analysis Framework

• 5.1. Global Gene Panel PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Gene Panel Market Growth Rate Analysis
• 5.4. Global Gene Panel Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Gene Panel Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Gene Panel Total Addressable Market (TAM)

6. Gene Panel Market Segmentation

• 6.1. Global Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Test Kits
• Testing Services
• 6.2. Global Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Amplicon-Based
• Hybridization-Based
• Other Technologies
• 6.3. Global Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Predesigned Gene Panel
• Customized Gene Panel
• 6.4. Global Gene Panel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer Risk Assessment
• Diagnosis Of Congenital Diseases
• Pharmacogenetics
• Other Applications
• 6.5. Global Gene Panel Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Research Institutes
• Hospital
• Diagnosis Centers
• Pharmaceutical Companies
• Other End-Users
• 6.6. Global Gene Panel Market, Sub-Segmentation Of Test Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Predesigned Gene Panels
• Customized Gene Panels
• 6.7. Global Gene Panel Market, Sub-Segmentation Of Testing Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer Risk Assessment Panels
• Pharmacogenetic Testing Panels
• Neurological Disorder Panels
• Cardiovascular Disease Panels
• Rare Disease Panels

7. Gene Panel Market Regional And Country Analysis

• 7.1. Global Gene Panel Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Gene Panel Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gene Panel Market

• 8.1. Asia-Pacific Gene Panel Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gene Panel Market

• 9.1. China Gene Panel Market Overview
• 9.2. China Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gene Panel Market

• 10.1. India Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gene Panel Market

• 11.1. Japan Gene Panel Market Overview
• 11.2. Japan Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gene Panel Market

• 12.1. Australia Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gene Panel Market

• 13.1. Indonesia Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gene Panel Market

• 14.1. South Korea Gene Panel Market Overview
• 14.2. South Korea Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gene Panel Market

• 15.1. Western Europe Gene Panel Market Overview
• 15.2. Western Europe Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gene Panel Market

• 16.1. UK Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gene Panel Market

• 17.1. Germany Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gene Panel Market

• 18.1. France Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gene Panel Market

• 19.1. Italy Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gene Panel Market

• 20.1. Spain Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gene Panel Market

• 21.1. Eastern Europe Gene Panel Market Overview
• 21.2. Eastern Europe Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gene Panel Market

• 22.1. Russia Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gene Panel Market

• 23.1. North America Gene Panel Market Overview
• 23.2. North America Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gene Panel Market

• 24.1. USA Gene Panel Market Overview
• 24.2. USA Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gene Panel Market

• 25.1. Canada Gene Panel Market Overview
• 25.2. Canada Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gene Panel Market

• 26.1. South America Gene Panel Market Overview
• 26.2. South America Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gene Panel Market

• 27.1. Brazil Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gene Panel Market

• 28.1. Middle East Gene Panel Market Overview
• 28.2. Middle East Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gene Panel Market

• 29.1. Africa Gene Panel Market Overview
• 29.2. Africa Gene Panel Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Gene Panel Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Gene Panel Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gene Panel Market Competitive Landscape And Company Profiles

• 30.1. Gene Panel Market Competitive Landscape
• 30.2. Gene Panel Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Quest Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Intermountain Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

31. Gene Panel Market Other Major And Innovative Companies

• 31.1. Agilent Technologies Inc.
• 31.2. Illumina Inc.
• 31.3. Qiagen Inc.
• 31.4. OPKO Health Inc.
• 31.5. Myriad Genetics Inc.
• 31.6. Guardant Health Inc.
• 31.7. Invitae Corp.
• 31.8. Integrated DNA Technologies Inc.
• 31.9. Bio-Rad Laboratories Inc.
• 31.10. Novogene Corporation
• 31.11. Fulgent Genetics Inc.
• 31.12. MedGenome Inc.
• 31.13. OriGene Technologies Inc.
• 31.14. Centogene AG
• 31.15. Blueprint Genetics Inc.

32. Global Gene Panel Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gene Panel Market

34. Recent Developments In The Gene Panel Market

35. Gene Panel Market High Potential Countries, Segments and Strategies

• 35.1 Gene Panel Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Gene Panel Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Gene Panel Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer